Evaluation of K-RAS gene in colorectal cancer

Folia Histochemica et Cytobiologica

Volumn 41, Issue 2, 2003, Pages 97-100

  Okulczyk, Bogna ^a   Piotrowski, Zdzisław ^a   Kovalchuk, Oksana ^a   Niklińnski, Jacek ^a   Chyczewski, Lech ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Colorectal cancer; K RAS

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INFILTRATION; CANCER PALLIATIVE THERAPY; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CODON; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EXON; FEMALE; GENDER; GENE MUTATION; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MALE; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE;

EID: 0037251958     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Andreyev HJ, Norman AR, Cunningham D et al (1998) Kirsten ras mutation in patients with colorectal cancer; The multicenter "RASCAL" study. J Natl Cancer Inst 90: 675-684
2. Baker SJ, Fearon ER, Nigro JM (1989) Chromosome 17 deletion and p53 gene mutation in colorectal carcinomas. Science 244: 217-221
3. Benhattar J, Losi L, Chaubert P (1993) Prognostic significance of K-RAS mutation in colorectal carcinoma. Gastroenterology 104: 1044-1048
4. Campbell SL, Khrosavi Far R, Rossman KL, Clark GJ, Der CJ (1998) Increasing complexity of Ras signaling. Oncogene 17: 1395-1413
5. Chorazy M (1997) Molecular aspects of carcinogenesis (in Polish). Nowotwory 47: 251-263
6. Dong SM, Traverso G, Johnson C, Geng L, Favis R, Boynton K, Hibi K, Goodman SN, D Allesio M, Paty P, Hamilton SR, Sidransky D, Barany F, Levin B, Shuberb A, Kinzler KW, Vogelstein B, Jen J (2001) Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst 93: 858-865
7. Etoh T, Ueo H, Inoue H, Sato K, Utsunomiya T, Barnard GF, Kitano S, Mori M (2001) Clinical significance of K-RAS mutation in intraoperative tumor drainage blood from patients with colorectal carcinoma. Ann Surg Oncol 8: 407-412
8. Fearon ER, Volgelstein B (1998) A genetic model for colorectal tumorigenesis. Cell 5: 759-767
9. Font A, Abad A, Monzo M, Sanchez JJ, Guillot M, Manzano JL, Pinol M, Ojanguren I, Rossell R (2001) Prognostic value of K-RAS mutations and allelic imbalance on chromosome 18q in patients with resected colorectal cancer. Dis Colon Rectum 44: 549-557
10. Forrester K, Almoguera C, Han K (1987) Detection of high incidence of K-RAS oncogenes during human colon tumorigenesis. Nature 327: 298-303
11. George SM, Makinen M J, Jernvall P, Makela J, Vihko P, Karttunen TJ (2000) Classification of advanced colorectal carcinomas by tumor edge morphology: Evidence for different pathogenesis and significance of polypoid and nonpolypoid tumors. Cancer 89: 1901-1909
12. Grady WM, Myeroff LL, Swinler SE, Rajput A, Thiagalingam S, Lutterbaugh JD, Neumann A, Brattain MG, Chang J, Kim SJ, Kinzler KW, Vogelstein B, Willson JK, Markowitz S (1999) Mutational inactivation of transforming growth factor B receptor type II in microsatellite stable colon cancer. Cancer Res 59: 320-324
13. Iwao K, Nakamori S, Kameyama M (1998) Activation of the beta-catenin gene by interstial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res 58: 1021-1026
14. Kopreski MS, Benko FA, Kwee C, Leitzel KE, Eskander E, Lipton A, Gocke CD (1997) Detection of mutant K-RAS DNA in plasma or serum of patients with colorectal cancer. Br J Cancer 76: 1293-1299
15. Lauschke H, Caspari R, Friedl W, Schwarz B, Mathiak M, Proppin GP, Hirner A (2001) Detection of APC and K-RAS mutations in the serum of patients with colorectal cancer. Cancer Detect Prev 25: 55-61
16. Notarnicola M, Cavallini A, Cardone R, Pezzola F, Demma J, Di-Leo A (2000) K-RAS and p53 mutations in DNA extracted from colonic epithelial cells exfoliated in faeces of patients with colorectal cancer. Dig Liver Dis 32: 131-136
17. Puig P, Urgell E, Capella G (2000) A highly sensitive method for K-RAS mutation detection is useful in diagnosis of gastrointestinal cancer. Int J Cancer 85: 73-77
18. Salbe C, Trevisiol C, Ferruzzi E, Mancuso T, Nascimbeni R, Di Fabio F, Salerni B, Dittadi R (2000) Molecular detection of codon 12 K-RAS mutations in circulation q DNA from serum of colorectal cancer patients. Int J Biol Markers 15: 300-307
19. Trzeciak L, Przybyszewska M, Nasierowska-Guttmejer A, Kołodziejski J, Nowacki M, Janik P, Ostrowski J (2000) K-RAS mutations and P53 protein accumulation in colorectal cancers (in Polish). Nowotwory 50: 21-27
20. Yashioro M, Carethers JM, Laghi L, Saito K, Slezak P, Jaramillo E, Rubio C, Koizumi K, Mirakawa K, Boland CR (2001) Genetic pathways in the evolution of morphologically distinct colorectal neoplasms. Cancer Res 61: 2676-2683
21. Zatoński W, Tyczyński J (1999) Malignant neoplasms in Poland in 1996 (in Polish). Centrum Onkologii - Instytut M. Skłodowskiej-Curie, Warszawa